Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

GILD US Equity

Gilead Sciences, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 882095 · FY ends Dec 31
$147.60
+4.16 (+2.90%)
USD · as of 2026-08-19 · marketstack
10 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-048-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-208-K 8.01Other eventssec.gov ↗
2026-05-208-K 2.03Creation of a direct financial obligationsec.gov ↗
2026-05-208-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-05-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-05-048-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-04-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by VANGUARD CAPITAL MANAGEMENT LLCsec.gov ↗
2026-04-288-K 8.01Other eventssec.gov ↗
2026-04-288-K 7.01Regulation FD disclosuresec.gov ↗
2026-03-2613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2026-02-238-K 7.01Regulation FD disclosuresec.gov ↗
2026-02-238-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-02-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-0513GSchedule 13G filed — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2025-11-198-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2025-10-308-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-068-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-06

Every row is a filed document, checked against its EDGAR index.